论文部分内容阅读
本文对22例妇科肿瘤病人进行血清CA~(125)检测,其中5例为复发或未治的卵巢上皮类腺癌患者,血清CA~(125)值均在317～500u/ml以上;余CA~(125)值低于67u/ml,包括1例治愈的卵巢上皮类腺癌、2例卵巢内胚窦瘤、5例卵巢良性肿瘤、3例恶性葡萄胎、4例宫肌瘤和宫颈癌、宫体癌各一例。 血清CA~(125)检测对卵巢上皮类腺癌的诊断有一定参考价值,至于是否有显著特异性及对早期病例有否诊断意义则有待进一步探讨。
In this paper, serum CA 125 was detected in 22 cases of gynecologic oncology patients, including 5 cases of recurrent or untreated ovarian epithelial adenocarcinoma, the serum CA125 values were over 317-500u / ml; ~ (125) value of less than 67u / ml, including 1 case of cured ovarian epithelial adenocarcinoma, 2 cases of ovarian endodermal sinus tumor, 5 cases of benign ovarian tumors, 3 cases of malignant mole, 4 cases of uterine fibroids and cervical cancer Palace body cancer each case. Serum CA125 detection has certain reference value for the diagnosis of ovarian epithelial adenocarcinoma. Whether there is significant specificity and whether it has diagnostic significance for early cases remains to be further explored.